Company Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Equities

600721

CNE000000KQ1

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs

XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-17 pm EDT			5-day change	1st Jan Change
5.2 ^CNY	0.00%		-12.16%	-32.82%

2023	Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	CI
2023	Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Xinjiang Bai Hua Cun Pharma Tech Co Ltd is a China-based company principally engaged in pharmaceutical services. The Company's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The Company is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The Company is also engaged in leasing and property services. The Company mainly conducts business within the domestic market.

Number of employees: 731

CNY in Million	2021	Weight	2022	Weight	Delta
Pharmaceutical Research and Development and Consistency Evaluation 52.5 %	140	49.8 %	184	52.5 %	+31.14%
Clinical Trials 38.8 %	107	37.9 %	136	38.8 %	+27.35%
Leasing and Property Service 6.4 %	31	11.0 %	22	6.4 %	-27.80%
Principal Business - Other 1.2 %	0	0.1 %	4	1.2 %	+1,976.54%
Advertise 1.0 %	3	1.1 %	3	1.0 %	+10.79%
Trademark Use Rights 0.0 %	0	0.0 %	0	0.0 %	0.00%
Other 0.0 %	0	0.0 %	0	0.0 %	-55.25%

CNY in Million	2021	Weight	2022	Weight	Delta
China 100.0 %	281	100.0 %	350	100.0 %	+24.36%

Managers	Title	Age	Since
Hui Huang CEO	Chief Executive Officer	40	20-12-23
Zi Yun Cai DFI	Director of Finance/CFO	51	17-11-23
Yan Xia BRD	Director/Board Member	44	21-09-16
Zheng Tian Lü BRD	Director/Board Member	60	15-05-12
Li Juan Han IRC	Investor Relations Contact	33	23-04-11

Members of the board	Title	Age	Since
Jing Song Wang BRD	Director/Board Member	60	21-09-16
Da Ming Li BRD	Director/Board Member	57	18-08-27
Li Gu BRD	Director/Board Member	55	Dec. 20
Hui Huang CEO	Chief Executive Officer	40	20-12-23
Xing Yu Lu BRD	Director/Board Member	36	21-09-16
Qing Yang BRD	Director/Board Member	61	19-09-05
Jian Bin Sun BRD	Director/Board Member	52	19-09-05
Bin Ma CHM	Chairman	52	19-09-05
Yan Xia BRD	Director/Board Member	44	21-09-16
Lei Meng BRD	Director/Board Member	41	21-09-16

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	381,822,020	210,836,664 ( 55.22 %)	0	55.22 %

Name	Equities	%	Valuation
Western Leadbank Fund Management Co., Ltd 0.1252 %	469,700	0.1252 %	405 530 ¥
GF Fund Management Co., Ltd. 0.000107 %	400	0.000107 %	345 ¥

Xinjiang Baihuacun Pharam Tech Co., Ltd.

1 South Lane Zhongshan Road

830002, Urumqi

http://www.xjbhc.net

address Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd(600721)

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD	-32.82%	274M
VERTEX PHARMACEUTICALS INCORPORATED	-2.63%	102B
REGENERON PHARMACEUTICALS, INC.	+3.17%	96.07B
ARGENX SE	-1.28%	21.66B
BIONTECH SE	-18.24%	20.77B
GENMAB A/S	-7.22%	18.53B
WUXI APPTEC CO., LTD.	-40.31%	16.91B
BEIGENE, LTD.	-28.61%	13.79B
NEUROCRINE BIOSCIENCES, INC.	+0.50%	13.33B
SAREPTA THERAPEUTICS, INC.	+21.40%	10.94B

Bio Therapeutic Drugs